Budesonide/Glycopyr/Formoterol
Brand name: Breztri Aerosphere
Rank #66 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$280.9M
Total Cost
340,138
Total Claims
$280.9M
Total Cost
8,916
Prescribers
$826
Cost per Claim
62,989
Beneficiaries
430,334
30-Day Fills
$32K
Avg Cost/Provider
38
Avg Claims/Provider
Share of Medicare Part D Spending
0.10%
of total Medicare Part D spending
$280.9M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $280.9M total
Top Prescribers of Budesonide/Glycopyr/Formoterol
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Humam Farah | Pulmonary Disease | Hannibal, MO | 895 | $721K |
| 2 | Jorge Sanchez-Masiques | Pulmonary Disease | Miami, FL | 981 | $660K |
| 3 | David Pham | Pulmonary Disease | Westminster, CA | 824 | $655K |
| 4 | Hoang Le | Pulmonary Disease | Fountain Valley, CA | 794 | $643K |
| 5 | Yoel Brito | Pulmonary Disease | Miami, FL | 869 | $613K |
| 6 | Milledge Newton | Pulmonary Disease | Valdosta, GA | 541 | $483K |
| 7 | Mohammad-Ali El-Harakeh | Internal Medicine | Prescott, AZ | 537 | $450K |
| 8 | Kari Hill | Nurse Practitioner | Grand Rapids, MI | 528 | $423K |
| 9 | Hisham Bismar | Critical Care (Intensivists) | Fort Worth, TX | 329 | $422K |
| 10 | Deketra Mcdowell-Willis | Nurse Practitioner | Las Vegas, NV | 470 | $413K |
| 11 | Ernesto Mejia | Pulmonary Disease | Morristown, TN | 483 | $389K |
| 12 | Philip Simkovitz | Pulmonary Disease | Trumbull, CT | 305 | $388K |
| 13 | Kelly Dudley | Nurse Practitioner | Augusta, ME | 288 | $376K |
| 14 | Steven Kong | Physician Assistant | Brooklyn, NY | 533 | $376K |
| 15 | Umer Siddiqui | Pulmonary Disease | Washington, MO | 450 | $355K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 63 | Rsv Vacc, Pref A And Pref B/Pf (Abrysvo) | $284.5M | 872,396 |
| 64 | Bimatoprost (Lumigan) | $284.4M | 610,243 |
| 65 | Apremilast (Otezla) | $283.9M | 59,020 |
| 66 | Budesonide/Glycopyr/Formoterol (Breztri Aerosphere) | $280.9M | 340,138 |
| 67 | Selexipag (Uptravi) | $279.1M | 12,320 |
| 68 | Liraglutide (Victoza 3-Pak) | $273.0M | 189,358 |
| 69 | Elexacaftor/Tezacaftor/Ivacaft (Trikafta) | $269.3M | 9,821 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology